TARGET
saveCD19
B-cell surface marker; CAR-T and bispecific target.
also known as: b-lymphocyte antigen cd19
🐶 often sniffed alongside
top 6drugs
0
catalysts
0
news
75
companies
0
Top drugs
no drugs tagged with this interest yet
🐶 Top companies
no companies tagged with this interest yet
Recent catalysts
no catalysts tagged with this interest yet
Recent news
view all →- Weighing the risks of CAR T in autoimmune disease as Kyverna nears marketbiospace · 6h ago
- Foghorn cuts 40% of workforcebiospace · 2d ago
- Novartis wagers almost $8B on a Chinese biotech’s RNA drugsbiopharma dive · 2d ago
- Novartis takes rights to Abogen's mRNA T cell engager for $575M upfrontendpoints · 3d ago
- Novartis pens $7.8B deal for Abogen's in vivo autoimmune T-cell engagerfiercebiotech · 3d ago
- Chutes & Ladders—Bayer taps new chief medical officer; Cantor appointed PhRMA CEOfiercebiotech · 3d ago
- ai3Bio emerging from stealth to ‘take the gun out of the hands of the immune system’fiercebiotech · 6d ago
- Adicet Bio CAR-T sparks lupus remissions in early trial as ‘new era’ of autoimmune treatment approachesfiercebiotech · 9d ago
Data sources
last refreshed 1h ago
Found something off?
comments(0)
5-min edit window · permanent after that